ImageneBio (IMA) Total Liabilities (2020 - 2024)

Historic Total Liabilities for ImageneBio (IMA) over the last 5 years, with Q3 2024 value amounting to $14.8 million.

  • ImageneBio's Total Liabilities fell 4757.34% to $14.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $14.8 million, marking a year-over-year decrease of 4757.34%. This contributed to the annual value of $22.3 million for FY2023, which is 1168.45% down from last year.
  • ImageneBio's Total Liabilities amounted to $14.8 million in Q3 2024, which was down 4757.34% from $14.6 million recorded in Q2 2024.
  • Over the past 5 years, ImageneBio's Total Liabilities peaked at $78.5 million during Q3 2020, and registered a low of $14.6 million during Q2 2024.
  • Its 5-year average for Total Liabilities is $40.4 million, with a median of $34.8 million in 2022.
  • In the last 5 years, ImageneBio's Total Liabilities crashed by 5908.3% in 2023 and then surged by 32.22% in 2024.
  • Quarter analysis of 5 years shows ImageneBio's Total Liabilities stood at $63.5 million in 2020, then crashed by 36.98% to $40.0 million in 2021, then tumbled by 36.78% to $25.3 million in 2022, then dropped by 11.68% to $22.3 million in 2023, then tumbled by 33.93% to $14.8 million in 2024.
  • Its Total Liabilities was $14.8 million in Q3 2024, compared to $14.6 million in Q2 2024 and $17.4 million in Q1 2024.